COVID-19 STEMI related to microthrombi may lead to coronary microvascular dysfunction.
Dalia AzizMehmet YildizOdayme QuesadaTimothy D HenryPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
Coronavirus disease 2019 (COVID-19) increases the risk of ST-segment elevation myocardial infarction (STEMI), and is associated with a higher occurrence of nonobstructive coronary artery disease. We present a unique case of STEMI with concomitant COVID-19 infection in a young female found to have slow flow in multiple vessels on angiography, likely due to microvascular thrombi. Three months later, the patient developed coronary microvascular dysfunction (CMD), suggesting an evolution of microvascular thrombi and injury into subsequent CMD.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- coronary artery disease
- coronavirus disease
- st elevation myocardial infarction
- coronary artery bypass grafting
- sars cov
- cardiovascular events
- acute coronary syndrome
- coronary artery
- respiratory syndrome coronavirus
- oxidative stress
- optical coherence tomography
- risk assessment
- aortic stenosis
- atrial fibrillation
- heart failure
- cardiovascular disease
- drug induced